Showing 81 - 100 results of 27,626 for search '(( end point decrease ) OR ( 50 ((((ng decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 0.74s Refine Results
  1. 81

    Brivanib decreases viability of PDGF-BB treated LX-2 cells. by Ikuo Nakamura (548298)

    Published 2014
    “…Cells showed a brivanib dose-dependent decrease in viability, with half maximal inhibitory concentration (IC<sub>50</sub>) of 16.98 µM (95% CI 13.95 µM–20.67 µM). …”
  2. 82
  3. 83
  4. 84
  5. 85
  6. 86
  7. 87

    BC−/EC+ exhibited increased end-systolic and end-diastolic volume and decreased left ventricular function 3 weeks post MI. by Simone Gorressen (605474)

    Published 2015
    “…<p>BC−/EC+ exhibited an increase in end-systolic (<b>A</b>) and end-diastolic volume (<b>B</b>), a significantly more pronounced decrease in stroke volume (<b>C</b>) (BC+/EC+ n = 8 and BC−/EC+ n = 5; two-way ANOVA and Bonferroni’s post hoc test or student’s t-test; * p<0.05, ** p≤ 0.01 BC+/EC+ vs. …”
  8. 88

    Un- and refolding kinetics of CMPK wt – Chevron Plot and end point analysis. by Thorsten Beitlich (478192)

    Published 2013
    “…While the slow transitions show constant amplitudes (symbols like in (a)), the amplitude of the fast transition decreases and turns negative at 2.0 M urea. (c) End-point analysis of the unfolding and refolding transitions. …”
  9. 89
  10. 90

    Decrease in cell viability by siRNA and miRNA dependent induction of DTA. by Liraz Harel (675561)

    Published 2014
    “…<p>U251 cells were transfected with the indicated construct (50 ng) with (A) or without (B) siRNAs (10pmol). …”
  11. 91
  12. 92
  13. 93

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
  14. 94
  15. 95
  16. 96

    The NG50 of ccTSA on datasets from 4 organisms with different sequence coverage and k-mer values. by Jung Ho Ahn (157844)

    Published 2012
    “…The k-mer values were varied from 19 to 35 on 36 bp data and from 37 to 73 on 76 bp data. In most datasets, NG50 values increased then decreased as we increased the k-mer values. …”
  17. 97
  18. 98
  19. 99
  20. 100

    Thyromental height test as a new method for prediction of difficult intubation with double lumen tube by Piotr Palczynski (5745908)

    Published 2018
    “…The optimal sensitivity and specificity values of thyromental height test were met with a cut off value of 50 mm. With 1 mm increase in thyromental height test, risk of difficult intubation decreased by 7%.…”